Eli Lilly’s Diversification Offers Stronger Investment Case
Beyond its weight-loss drug success, Eli Lilly's robust pipeline across oncology, immunology, and neuroscience presents a compelling investment thesis.
Beyond its weight-loss drug success, Eli Lilly's robust pipeline across oncology, immunology, and neuroscience presents a compelling investment thesis.
Cotton futures experienced a positive start to the week, with contracts closing higher. This strength coincided with a weakening US dollar and...
A significant shift is underway as one in four S&P 500 companies now report quantifiable AI impacts, up from 13% a year...
Upcoming earnings from BYD and Geely will be crucial for investors assessing the diverging performance of China's top EV makers, with focus...
Rambus forecasts second-quarter revenue between $192 million and $198 million, with non-GAAP earnings per share projected at $0.65 to $0.73.
A fraud victim recovered £20,000 from Lloyds after a BBC investigation, highlighting calls to reform the 13-month deadline for reporting scams.
Gold and silver prices dropped significantly as the U.S. and Iran's diplomatic stalemate intensified, with the Strait of Hormuz remaining closed, fueling...
Malaysia's Kuala Lumpur Composite Index, down for two sessions, is anticipated to find support on Tuesday. Global uncertainties, including Middle East tensions...
Beijing has halted Meta's $2 billion purchase of AI startup Manus, citing national security concerns and export control laws. The decision marks...
Affirm's 'agentic credit' model leverages real-time data and AI to underwrite transactions, not just consumers, potentially expanding access and improving transparency in...
India and New Zealand have signed a comprehensive free-trade agreement, eliminating tariffs on most goods and expanding market access for both nations.
Bango PLC announced its full-year financial results, reporting a 2.2% decrease in revenue to $52.2M. However, Annual Recurring Revenue (ARR) saw a...